2026 Q1 -tulosraportti
80 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·4 t sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊
A10A You have repeatedly denied that Novo should have been in crisis. Have you looked closer at the financial figures since you can now confirm there has been a crisis, or have you merely listened, and read and understood my posts? Better late than never with an objective perspective from you. Good to see that it's not just hype coming from your side.
·5 t sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
·5 t sittenIt is important that Danish-taxed private investors in free portfolios follow their investment plans and realize capital losses when they, for example, hit 5%; but it is also important to have a plan for reinvesting the proceeds. The proceeds should be used to buy new positions, and they should never be used to impair position gain shares on the portfolio's existing positions. If one is not able to follow their "stop loss investment plan", one will get a red loss ladder to the left of the green gain ladder and cheat oneself out of a tax offset of 42% of the realized capital losses: https://cdn.prod.nntech.io/shareville-media/groups/b18bc438-9572-45a1-addf-a5ca95abec68/logos/95fab8b7-9425-475f-b6c5-b9f7112c7242.png- ·8 t sitten · MuokattuStrong and professional interview with Novo Nordisk, which among other things states that there is no excuse for Lilly consistently comparing older Novo data with New Lilly data. Something that in the end can mean that patients and doctors make incorrect professional decisions. https://m.youtube.com/watch?v=MQIoHsCWSxw&pp=ygUJTm92byBzdWVz0gcJCaMLAYcqIYzv&ra=mIt could be interesting to hear a similar interview with Lilly where they don't just categorically reject the accusation. But they probably don't have much desire for that.
·10 t sittenWon't there be an upward revision from Novo in the coming week in a pre announcement ahead of Q2 on Aug. 5th?I would, however, argue (could it be different understandings of) that the Novo share price, after a free fall, had fallen too far. Something one often sees, just like when something goes up too high. Fundamentals are important but sentiments can take over for a period. This is where good buys/sells can be found.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
80 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·4 t sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊A10A You have repeatedly denied that Novo should have been in crisis. Have you looked closer at the financial figures since you can now confirm there has been a crisis, or have you merely listened, and read and understood my posts? Better late than never with an objective perspective from you. Good to see that it's not just hype coming from your side.
- ·5 t sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
- ·5 t sittenIt is important that Danish-taxed private investors in free portfolios follow their investment plans and realize capital losses when they, for example, hit 5%; but it is also important to have a plan for reinvesting the proceeds. The proceeds should be used to buy new positions, and they should never be used to impair position gain shares on the portfolio's existing positions. If one is not able to follow their "stop loss investment plan", one will get a red loss ladder to the left of the green gain ladder and cheat oneself out of a tax offset of 42% of the realized capital losses: https://cdn.prod.nntech.io/shareville-media/groups/b18bc438-9572-45a1-addf-a5ca95abec68/logos/95fab8b7-9425-475f-b6c5-b9f7112c7242.png
- ·8 t sitten · MuokattuStrong and professional interview with Novo Nordisk, which among other things states that there is no excuse for Lilly consistently comparing older Novo data with New Lilly data. Something that in the end can mean that patients and doctors make incorrect professional decisions. https://m.youtube.com/watch?v=MQIoHsCWSxw&pp=ygUJTm92byBzdWVz0gcJCaMLAYcqIYzv&ra=mIt could be interesting to hear a similar interview with Lilly where they don't just categorically reject the accusation. But they probably don't have much desire for that.
- ·10 t sittenWon't there be an upward revision from Novo in the coming week in a pre announcement ahead of Q2 on Aug. 5th?I would, however, argue (could it be different understandings of) that the Novo share price, after a free fall, had fallen too far. Something one often sees, just like when something goes up too high. Fundamentals are important but sentiments can take over for a period. This is where good buys/sells can be found.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
2026 Q1 -tulosraportti
80 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·4 t sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊A10A You have repeatedly denied that Novo should have been in crisis. Have you looked closer at the financial figures since you can now confirm there has been a crisis, or have you merely listened, and read and understood my posts? Better late than never with an objective perspective from you. Good to see that it's not just hype coming from your side.
- ·5 t sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
- ·5 t sittenIt is important that Danish-taxed private investors in free portfolios follow their investment plans and realize capital losses when they, for example, hit 5%; but it is also important to have a plan for reinvesting the proceeds. The proceeds should be used to buy new positions, and they should never be used to impair position gain shares on the portfolio's existing positions. If one is not able to follow their "stop loss investment plan", one will get a red loss ladder to the left of the green gain ladder and cheat oneself out of a tax offset of 42% of the realized capital losses: https://cdn.prod.nntech.io/shareville-media/groups/b18bc438-9572-45a1-addf-a5ca95abec68/logos/95fab8b7-9425-475f-b6c5-b9f7112c7242.png
- ·8 t sitten · MuokattuStrong and professional interview with Novo Nordisk, which among other things states that there is no excuse for Lilly consistently comparing older Novo data with New Lilly data. Something that in the end can mean that patients and doctors make incorrect professional decisions. https://m.youtube.com/watch?v=MQIoHsCWSxw&pp=ygUJTm92byBzdWVz0gcJCaMLAYcqIYzv&ra=mIt could be interesting to hear a similar interview with Lilly where they don't just categorically reject the accusation. But they probably don't have much desire for that.
- ·10 t sittenWon't there be an upward revision from Novo in the coming week in a pre announcement ahead of Q2 on Aug. 5th?I would, however, argue (could it be different understandings of) that the Novo share price, after a free fall, had fallen too far. Something one often sees, just like when something goes up too high. Fundamentals are important but sentiments can take over for a period. This is where good buys/sells can be found.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt